High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 11, 2013, Pages 2542-2547

  Choy, Bonnie ^a   Findeis Hosey, Jennifer J ^a   Li, Faqian ^a   McMahon, Loralee A ^a   Yang, Qi ^a   Xu, Haodong ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Lung; Maspin; P53; P63; Squamous cell carcinoma

Indexed keywords

MASPIN; PROTEIN P53; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; TP53 PROTEIN, HUMAN; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADENOCARCINOMA; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; P63; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; LUNG; MASPIN; P53; P63; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; SERPINS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84887097715     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-529.
2. Maass N, Hojo T, Rosel F, Ikeda T, Jonat W and Nagasaki K. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 2001;34:303-307.
3. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W and Nagasaki K. Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 2001;7:812-817.
4. Bieche I, Girault I, Sabourin JC, Tozlu S, Driouch K, Vidaud M and Lidereau R. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas. Br J Cancer 2003;88:863-870.
5. Umekita Y, Ohi Y, Sagara Y and Yoshida H. Expression of maspin predicts poor prognosis in breast-cancer patients. Int J Cancer 2002;100:452-455.
6. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix MJ. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002;8:2924-2932.
7. Nakagawa M, Katakura H, Adachi M, Takenaka K, Yanagihara K, Otake Y, Wada H and Tanaka F. Maspin expression and its clinical significance in non-small cell lung cancer. Ann Surg Oncol 2006;13:1517-1523.
8. Takanami I, Abiko T and Koizumi S. Expression of maspin in non-small-cell lung cancer:correlation with clinical features. Clin Lung Cancer 2008;9:361-366.
9. Katakura H, Takenaka K, Nakagawa M, Sonobe M, Adachi M, Ito S, Wada H and Tanaka F. Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Maspin in NSCLC. Lung Cancer 2006;51:323-328.
10. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ and Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 1996;93:11669-11674.
11. Zhang M, Volpert O, Shi YH and Bouck N. Maspin is an angiogenesis inhibitor. Nat Med 2000;6:196-199.
12. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E and Srivastava S. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 2000;275:6051-6054.
13. Zhang M, Maass N, Magit D and Sager R. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ 1997;8:179-186.
14. Feldman RJ, Sementchenko VI, Gayed M, Fraig MM and Watson DK. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res 2003;63:4626-4631.
15. Kim S, Han J, Kim J and Park C. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res 2004;64:6900-6905.
16. Strano S, Rossi M, Fontemaggi G, Munarriz E, Soddu S, Sacchi A and Blandino G. From p63 to p53 across p73. FEBS Lett 2001;490:163-170.
17. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316.
18. Spiesbach K, Tannapfel A, Mossner J and Engeland K. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor. Int J Cancer 2005;114:555-562.
19. Massion PP, Taflan PM, Rahman SM, Yildiz P, Shyr Y, Carbone DP and Gonzalez AL. Role of p63 amplification and overexpression in lung cancer development. Chest 2004;125:102S.
20. Yatabe Y, Mitsudomi T and Takahashi T. Maspin expression in normal lung and non-small-cell lung cancers:cellular property-associated expression under the control of promoter DNA methylation. Oncogene 2004;23:4041-4049.
21. Akyildiz EU, Oz B, Sehitoglu I and Demir H. The diagnostic utility of maspin in the distinction between malignant mesothelioma and pulmonary adenocarcinoma. J Int Med Res 2010;38:1070-1076.
22. Nakashima M, Ohike N, Nagasaki K, Adachi M and Morohoshi T. Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma. J Cancer Res Clin Oncol 2004;130:475-479.
23. Zheng HC, Saito H, Masuda S, Wang ZG and Takano Y. Cytoplasmic and nuclear maspin expression in lung carcinomas:an immunohistochemical study using tissue microarrays. Appl Immunohistochem Mol Morphol 2008;16:459-565.
24. Frey A, Soubani AO, Adam AK, Sheng S, Pass HI and Lonardo F. Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival. Histopathology 2009;54:590-597.
25. Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K and Kawamoto M. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Ann Thorac Surg 2005;79:248-253.